Literature DB >> 455243

Hodgkin's cells and attached lymphocytes: a possible prognostic indicator in splenic tumor.

R A McGuire, T G Pretlow, T H Wareing, E L Bradley.   

Abstract

After the purification of Hodgkin's cells by a previously reported method from splenic tumor of 8 patients with Stages III or IV Hodgkin's disease, we have examined the proportions of Hodgkin's cells with attached lymphocytes. All patients were studied 3--5 years after staging laparotomy. Four patients had no recurrent disease; 3 had histologically confirmed recurrent disease; and 1 had clinically suspected recurrent disease (enlarged nodes) but has thus far refused further medical study and care. The proportion of purified Hodgkin's cells which had attached lymphocytes was consistently higher in the patients who were clinically free of disease. The possible biological significance of this observation is discussed briefly and would appear to warrant further investigation of this phenomenon in more patients with splenic tumor than are available to us.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455243     DOI: 10.1002/1097-0142(197907)44:1<183::aid-cncr2820440130>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Double and triple immunocytochemical labelling at the light microscope level in histopathology.

Authors:  T Krenács; L Krenács; B Bozóky; B Iványi
Journal:  Histochem J       Date:  1990-10

2.  The separation of human palatine tonsillar cells in the reorienting gradient zonal rotor: a large-capacity enrichment of plasma cells.

Authors:  D F Daugherty; J A Scott; T G Pretlow
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

3.  Reed-Sternberg/lymphocyte rosette: lymphocyte subpopulations as defined by monoclonal antibodies.

Authors:  C S Morris; A E Stuart
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

4.  Phorbol myristate acetate induced colony growth in Hodgkin's disease.

Authors:  L F Skinnider; W Maksymiuk; J McAskill
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.